Abstract:
South Africa is home to a variety of herbal teas, such as bush tea (Athrixia phylicoides
DC.), honeybush tea (Cyclopia intermedia E. Mey and C. subternata Vogel), special tea (Monsonia
burkeana Planch. ex Harv.), and rooibos tea (Aspalathus linearis (Burm.f.) R. Dahlgren) that are
known to possess anti-oxidant, anti-inflammatory and anti-diabetic properties. The objective of this
study was to determine the in vitro anti-oxidant activity of selected tea blends using 2,20-azino-bis(3-
ethylbenzthiazoline-6-sulfonic acid) (ABTS) and 1,1-diphenyl-2-picrylhydrazyl (DPPH) assays, as
well as to assess their anti-inflammatory properties using the 15-lipoxygenase inhibitory assay. Furthermore,
the study measured glucose utilisation in C2C12 myotubes. Lastly, 3-(4, 5-dimethylthiazol-
2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay was used to test the safety of the tea extracts on
Vero cells (African green monkey kidney cell line). Special tea and its blend with bush tea exhibited
potent anti-oxidant and anti-inflammatory activity. The blending of bush tea with special tea at
different ratios resulted in increased anti-oxidant activity. Although special tea had a level of cell
toxicity, its toxicity was lowered during blending. All of the tea samples showed anti-diabetic effects,
although with less potency as compared to insulin. The current investigation supports the use of
blended herbal teas, and the positive anti-inflammatory effect of special tea warrants further research.
